We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Visceral Adiposity, Insulin Resistance, and Type 2 Diabetes.
- Authors
Griffith, Michelle L.; Younk, Lisa M.; Davis, Stephen N.
- Abstract
The worldwide prevalence of obesity and obesity-related diseases continues to rise. Insulin resistance, the metabolic syndrome, and type 2 diabetes are all associated with obesity. Visceral fat is now recognized to have metabolic, endocrine, and immune functions; increased visceral adiposity enhances the risk of metabolic and cardiovascular disorders. Potential mechanisms of this increased risk may include increased free fatty acid release and alterations in adipokines. Lifestyle interventions resulting in weight loss and loss of visceral fat can have a significant impact on cardiometabolic risk. Bariatric surgery has also been shown to improve insulin resistance, type 2 diabetes, and other comorbidities of obesity. Several medical therapies for type 2 diabetes or obesity also show promise for an impact on visceral adiposity-related comorbidities.
- Publication
American Journal of Lifestyle Medicine, 2010, Vol 4, Issue 3, p230
- ISSN
1559-8276
- Publication type
Article
- DOI
10.1177/1559827609360959